Health Media ArticlesExcerpts of Key Health Media Articles in Major Media
Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
For further exploration, delve into our comprehensive Health and Food Corruption Information Center.
Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
Three years after the Food and Drug Administration first hinted that it might permit the sale of milk and meat from cloned animals...the agency is poised to endorse marketing of the mass-produced animals for public consumption. The decision...is based largely on new data indicating that milk and meat from cloned livestock and their offspring pose no unique risks to consumers. On Thursday, advocacy groups filed a petition asking the FDA to regulate cloned farm animals one type at a time, much as it regulates new drugs, a change that would drastically slow marketing approval. "The available science shows that cloning presents serious food safety risks, animal welfare concerns and unresolved ethical issues that require strict oversight," the petition states. "The government talks about being science-based, and that's great, but I think there is another pillar here: the question of whether we really want to do this," said Carol Tucker Foreman, director of food policy at the Consumer Federation of America. Each clone is a genetic replica of the animal that donated the cell from which it was grown. It was October 2003 when the FDA released its first draft document concluding that clones and their offspring are safe to eat. But an agency advisory panel and the National Academies, while generally supportive, raised flags, citing a paucity of safety data. Clonal meat or milk would be impossible to authenticate, since there is no way to distinguish them from conventional products. "That you can go online today to any number of different Web sites and purchase semen from cloned bulls tells you there are cloned sires out there fathering calves in the food supply."
Note: For an ABC article on this, click here. If you believe that government agencies are unbiased on matters of public health, I most highly urge you to read our summary at http://www.WantToKnow.info/deception10pg
Witold Bialokur...can run 10 kilometers, or 6.2 miles, in less than 44 minutes. While Mr. Bialokur’s performance would be the envy of most young men, he is not young. Mr. Bialokur is 71. It is one of the persistent mysteries of aging, researchers say. Why would one person, like Mr. Bialokur, remain so hale and hearty while another, who had seemed just as healthy, start to weaken and slow down? Rigorous studies are now showing that seeing, or hearing, gloomy nostrums about what it is like to be old can make people walk more slowly, hear and remember less well, and even affect their cardiovascular systems. Positive images of aging have the opposite effects. The constant message that old people are expected to be slow and weak and forgetful is not a reason for the full-blown frailty syndrome. But it may help push people along that path.
Schizophrenia patients do as well, or perhaps even better, on older psychiatric drugs compared with newer and far costlier medications, according to a study published yesterday that overturns conventional wisdom about antipsychotic drugs, which cost the United States $10 billion a year. The results are causing consternation. The researchers who conducted the trial were so certain they would find exactly the opposite that they went back to make sure the research data had not been recorded backward. The study was requested by Britain's National Health Service to determine whether the newer drugs -- which can cost 10 times as much as the older ones -- are worth the difference in price. While the researchers had expected a difference of five points on a quality-of-life scale -- showing the newer drugs were better -- the study found that patients' quality of life was slightly better when they took the older drugs. There has been a surge in prescriptions of the newer antipsychotic drugs in recent years, including among children. In an editorial accompanying the British study, the lead researcher in the U.S. trial asked how an entire medical field could have been misled into thinking that the expensive drugs, such as Zyprexa, Risperdal and Seroquel, were much better.
Note: Those who have read our two-page health cover-up summary know very well how the entire medical field could have been misled. For those who haven't seen it: http://www.WantToKnow.info/healthcoverup
Top officials at the Centers for Disease Control and Prevention received premium bonuses in recent years at the expense of scientists and others who perform much of the agency's scientific work. Those inside the office of the centers' director, Dr. Julie L. Gerberding, have benefited the most. From 2002 through mid-2006, William H. Gimson III, the agency's chief operating officer, received bonuses totaling $147,863. Before Dr. Gerberding's appointment, members of the C.D.C. director's inner circle rarely received premium bonuses. Because bonus money is limited...the growing share of premium bonuses for Dr. Gerberding's closest advisers has meant less money is available for some scientists and other workers. In addition to those within Dr. Gerberding's inner circle, the increase in large cash awards within the centers has mostly benefited employees in the agency's financial, computer and human resources departments -- not its scientists. Soon after arriving at the centers, Dr. Gerberding began a comprehensive reorganization of the agency. In its wake, many of the agency's senior scientists and leaders either left or have announced that they are planning to leave. The Washington Post and The Atlanta Journal-Constitution have reported on the turmoil at the centers in articles quoting disgruntled former senior scientists who said the changes had undermined the agency.
Note: Could it be that these bonuses are meant to keep top officials in line the the CDC's strong bias towards to pharmaceutical companies? For more vital information on this: http://www.WantToKnow.info/healthcoverup.
We have always been told there is no recovery from persistent vegetative state - doctors can only make a sufferer's last days as painless as possible. But is that really the truth? Across three continents, severely brain-damaged patients are awake and talking after taking ... a sleeping pill. Brain-damaged patients are reporting remarkable improvements after taking a pill that should make them fall asleep but that, instead, appears to be waking up cells in their brains that were thought to have been dead. No one yet knows exactly how a sleeping pill could wake up the seemingly dead brain cells, but [researchers] have a hypothesis. After the brain has suffered severe trauma, a chemical known as Gaba (gamma amino butyric acid) closes down brain functions in order to conserve energy and help cells survive. However, in such a long-term dormant state, the receptors in the brain cells that respond to Gaba become hypersensitive, and as Gaba is a depressant, it causes a persistent vegetative state. It is thought that during this process the receptors are in some way changed or deformed so that they respond to zolpidem differently from normal receptors, thus breaking the hold of Gaba. This could mean that instead of sending patients to sleep as usual, it makes dormant areas of the brain function again and some comatose patients wake up.
Note: For lots more on key health issues from reliable sources, click here.
Most of the federal scientists who improperly accepted personal money from drug or biotechnology companies walked away with reprimands or were allowed to retire unscathed. Only two of the 44 scientists found to have violated rules governing private consulting deals are being investigated for possible criminal activity, and they remain on the government payroll. NIH spokesman John Burklow said his agency wanted eight others reviewed for possible crimes, but those cases were rejected by the investigating office at the U.S. Health and Human Services Department. The two still outstanding...both committed "serious misconduct," so grave that they would be fired if they were civilians, NIH internal ethics reports contend. [A Congressional] subcommittee is expected to question NIH officials about documents showing it approved several taxpayer-paid trips for [Dr. Trey] Sunderland to attend conferences and events in places like Hawaii and Toronto, even after recommending his firing. Of the 44 alleged offenders...the majority received reprimands or warnings for failing to properly obtain approvals for their outside consulting work. NIH ethics reports allege...two scientists had unauthorized, unreported deals with drug companies -- Sunderland earning more than $600,000 over eight years for consulting and speeches and [Dr. Thomas] Walsh more than $100,000 in five years -- and that their consulting improperly overlapped with government duties.
Note: The Los Angeles Times later reported that Dr. Sunderland was the first NIH scientist in 14 years to be found guily of conflict of interest laws. For more vital information on major collusion between government and the pharmaceutical companies: http://www.WantToKnow.info/healthcoverup.
In 1972, the Tuskegee experiments on black people shocked the world. Now, a new report reveals that the official inquiry was a cover-up. The [syphilis] "trial," conducted between 1932 and 1972, involved 400 black sharecroppers. The Tuskegee "volunteers" were not to be treated, either with Salvarsan or even antibiotics after their discovery. Ignorant of the true goal of the trial, the participants were destined to be living, and dying, examples of the terrible course of the untreated illness. Tuskegee, after its exposure in the media in 1972, thus became a byword in America for racist medical experimentation. Soon after the Tuskegee revelations, fault was admitted, apologies made. Yet in time, historians of medicine, sociologists and social anthropologists began to play down the scandal. Tuskegee, they argued, was an understandable error, given the absence of viable antidotes in the 1930s. But renewed outrage over Tuskegee is about to explode with an investigation entitled Medical Apartheid, to be published in the US early next year. The public-health historian Harriet Washington will reveal ... that the Tuskegee trial was even more inhumane and morally degenerate than previously suspected. The role of Nurse Eunice Rivers became crucial. Above all, her task, aided by the study's doctors, was to ensure that the syphilitic men would receive no treatment, despite the extraordinary advances in treatment from the 1940s onwards. "By 1955," according to Washington, "nearly one-third of the autopsied men had died directly of syphilis and many of the survivors were suffering its deadliest complications."
Note: For lots more on the history humans used as guinea pigs in experiments by government: http://www.WantToKnow.info/humanguineapigs and http://www.WantToKnow.info/mindcontrollers10pg#human
Nearly 70 percent of the rescue and cleanup workers who toiled in the dust and fumes at ground zero have had trouble breathing, and many will probably be sick for the rest of their lives, doctors said Tuesday in releasing results of the biggest Sept. 11 health study yet. The Mount Sinai Medical Center study is conclusive proof of a link between recovery work at the World Trade Center ruins and long-term respiratory problems, doctors aid.
The level of nicotine that smokers typically consume per cigarette has risen 10 percent in the past six years, making it harder to quit and easier to be addicted, said a report that the Massachusetts Department of Health released on Tuesday. The study shows a steady increase in the amount of nicotine delivered to the smokers? lungs regardless of brand, with overall yields increasing 10 percent. Massachusetts is one of three states to require tobacco companies to submit information on nicotine testing to its specifications and is the sole state with data as far back as 1998. The study found that the three most popular brands with young smokers, Marlboro, Newport and Camel, delivered significantly more nicotine than they did six years ago. Nicotine consumed in Kool, a popular menthol brand, rose 20 percent.
Rice farmers in Arkansas, Missouri, Mississippi, Louisiana, Texas and California have sued Bayer CropScience, alleging its genetically modified rice has contaminated the crop. The farmers alleged that the unit of Germany's Bayer AG
Note: Why did no major media report this important story in the U.S.? Only the Christian Science Monitor mentioned it. The media rarely reports anything negative about genetically modified food. To learn about the dangers of GMOs in the food you eat: http://www.WantToKnow.info/deception10pg
For years, scientists have looked at the placebo effect as just a figment of overactive patient imaginations. Sure, dummy medications seemed to curb epileptic seizures, lower blood pressure, soothe migraines and smooth out jerky movements in Parkinson's -- but these people weren't really better. Now, using PET scanners and MRIs ... researchers have discovered that the placebo effect is not "all in patients' heads" but rather, in their brains. New research shows that belief in a dummy treatment leads to changes in brain chemistry. Says Dr. Michael Selzer, professor of neurology at the University of Pennsylvania School of Medicine, "After pooh-poohing this for years, here are studies that show that our thoughts may actually interact with the brain in a physical way." New insights into how placebos work may even help scientists figure out how to harness the effect and teach people to train their own brains to help with healing. Studies in depressed patients ... have found that almost as many are helped by placebo treatments as by actual medications. Researchers are just starting to appreciate the power that the mind can have over the body. Part of what goes into the brain's interpretation is expectation. By changing the expectancy and bumping up the placebo response we might be able to ultimately find a way to provide sustained therapy for chronic pain.
A federal judge ruled yesterday that tobacco companies have violated civil racketeering laws, concluding that cigarette makers conspired for decades to deceive the public about the dangers of their product. But U.S. District Judge Gladys Kessler said that under a 2005 appellate court ruling, she could not impose billions of dollars in penalties that had been sought by the Justice Department in its civil racketeering suit. In the opinion...Kessler wrote that there is "overwhelming evidence" [that the industry] conspired to violate, and indeed violated, federal racketeering laws. "In short," she wrote, "defendants have marketed and sold their lethal product with zeal, with deception, with a single-minded focus on their financial success, and without regard for the human tragedy or social costs that success exacted. Over the course of more than 50 years, defendants lied, misrepresented and deceived the American public, including smokers and the young people...about the devastating health effects of smoking and environmental tobacco smoke." Kessler added that the companies "suppressed research, they destroyed documents, they manipulated the use of nicotine so as to increase and perpetuate addiction...and they abused the legal system in order to achieve their goal -- to make money." The Justice Department lawsuit originally sought $280 billion. But the U.S. Court of Appeals [ruled] a company could not be forced to turn over past profits as a way of preventing future misconduct. The Justice Department subsequently proposed a $130 billion penalty to pay for anti-smoking programs, but...it scaled that back to a total of $14 billion.
As many as one in 300 HIV patients never get sick and never suffer damage to their immune systems and AIDS experts said on Wednesday they want to know why. Most have gone unnoticed by the top researchers, because they are well, do not need treatment and do not want attention, said Dr. Bruce Walker of Harvard Medical School. But Walker and colleagues want to study these so-called "elite" patients in the hope that their cases can help in the search for a vaccine or treatments. So far Walker and colleagues have not been able to find out why certain people can live for 15 years and longer with the virus and never get ill. The AIDS virus usually kills patients within two years if they are not treated. Walker has tracked down 200 elite patients and has now joined up with other prominent AIDS researchers to find at least 1,000 "elites" in North America and as many as possible globally.
A shell coated with depleted uranium pierces a tank like a hot knife through butter. It also leaves behind a fine radioactive dust with a half-life of 4.5 billion years. Depleted uranium is the garbage left from producing enriched uranium for nuclear weapons and energy plants. At Walter Reed Army Medical Center in Washington, D.C., [Herbert Reed] ran into a buddy from his unit. And another, and another. They began to talk. [They] all have depleted uranium in their urine. The veterans, using their positive results as evidence, have sued the U.S. Army, claiming officials knew the hazards of depleted uranium, but concealed the risks. The Department of Defense says depleted uranium is powerful and safe. Military research on mice shows that depleted uranium can enter the bloodstream and come to rest in bones, the brain, kidneys and lymph nodes. Other research in rats shows that DU can result in cancerous tumors and genetic mutations. Fifteen years after it was first used in battle, there is only one U.S. government study monitoring veterans exposed to depleted uranium. Number of soldiers in the survey: 32. Depleted uranium falls into the quagmire of Gulf War Syndrome, from which no treatment has emerged. About 30 percent of the 700,000 men and women who served in the first Gulf War still suffer [this] baffling array of symptoms. Depleted uranium has long been suspected as a possible contributor. It took more than 25 years for the Pentagon to acknowledge that Agent Orange...was linked to [major disease and] sufferings. It took 40 years for the military to compensate sick World War II vets exposed to massive blasts of radiation during tests of the atomic bomb.
Note: Why isn't the media reporting more on this health disaster? For lots more on how veterans suffer from corporate and governmental denial and manipulations, see what a highly decorated U.S. General has to say on the suffering of soldiers at http://www.WantToKnow.info/warcoverup. For an amazingly revealing documentary with interviews from top sources on the depleted uranium cover-up, click here.
When a medical crisis hits, people want to know that someone smart in a white coat can prescribe Prozac to boost their mood, perform heart surgery to open their clogged arteries, or administer chemotherapy, radiation or surgery to cure them of cancer. But growing numbers of Americans are also eager to experiment with alternative therapies. A natural tension has long existed between these two kinds of medicine. Western medical practitioners have been wary of the sometimes wacky-sounding, often-untested therapies in alternative medicine's toolkit. Alternative medicine practitioners have typically operated outside the conventional system, with consumers paying out of pocket. But over the last 10 years this wall has started, partially, to erode. Aided by federal funds, an increasing number of alternative therapies have been put to Western-style clinical tests, separating ones that seem beneficial, such as acupuncture for relief of pain, meditation to reduce hypertension, or ginger to relieve nausea -- from the chaff that appears ineffective. And conventional practitioners have come to appreciate the effect of the mind on chronic pain, heart disease, autoimmune conditions, anxiety and depression -- even the progress of disease.
Medicare's drug benefit has given a shot in the arm to pharmaceutical companies and insurers, whose revenue is climbing thanks to government subsidies for prescription medicine. What's happened so far: Drugmakers including GlaxoSmithKline and Pfizer reported higher-than-expected sales and profit in the second quarter, with some of the momentum coming from Medicare. Meanwhile, membership rolls of big insurers, including UnitedHealth Group and Humana, are mushrooming as Medicare beneficiaries sign up for drug plans. Drug companies -- which successfully thwarted price-control attempts -- are reaping the rewards of more seniors and disabled people getting access to their medications. British drugmaker GlaxoSmithKline's second-quarter net income grew 14 percent over the same quarter last year due in part to strong Medicare drug sales. Merck & Co., Schering Plough, Wyeth, Roche and Pfizer ... all exceeded analysts' expectations, reflecting sales boosts from the program. In the first three months of the benefit, brand-name drug prices rose 4 percent, according to a report from the AARP. WellPoint Inc., the nation's largest insurer, reported second-quarter profit gains of 34 percent. UnitedHealth ... posted quarterly profit gains of 26 percent. Humana reported earlier this week its second-quarter profit increased 9.9 percent and revenue jumped 52 percent over the same quarter last year, due in large part to a surge in Medicare membership. The insurer expects annual revenue to grow by 50 percent.
Note: This article fails to mention who pays for all these profits -- our tax dollars. To understand the degree of corruption in the pharmaceutical industry, read a two-page summary by one of the most respected MDs in the U.S. at http://www.WantToKnow.info/healthcoverup
In 2002, [a] German-born molecular geneticist startled the scientific world by creating the first live, fully artificial virus in the lab. It was a variation of the bug that causes polio. The virus was made wholly from nonliving parts, using equipment and chemicals on hand. The most crucial part, the genetic code, was picked up for free on the Internet. The new technology opens the door to new tools for defeating disease and saving lives. But today, in hundreds of labs worldwide, it is also possible to transform common intestinal microbes into killers. Or to resurrect bygone killers, such the 1918 influenza. New techniques...allow the creation of synthetic viruses in mere days. Hardware unveiled last year by a Harvard genetics professor can churn out synthetic genes by the thousands, for a few pennies each. The U.S. Centers for Disease Control and Prevention has declined so far to police the booming gene-synthesis industry. "It would be possible -- fully legal -- for a person to produce full-length 1918 influenza virus or Ebola virus genomes," said Richard H. Ebright, a biochemist and professor at Rutgers University. "It is also possible to advertise and to sell the product." Five years after the Sept. 11 attacks, the federal government budgets nearly $8 billion annually -- an 18-fold increase since 2001 -- for the defense of civilians against biological attack. Billions have been spent to develop and stockpile new drugs, most of them each tied to a single, well-known bioterrorism threat, such as anthrax. If successful, [each] drug is a solution for just one disease threat out of a list that is rapidly expanding to include man-made varieties.
Note: The government research lab at Fort Detrick, Maryland, has been secretly developing this technology for decades. For serious questions on the role of secret government projects in deadly disease creation and dissemination, see http://www.WantToKnow.info/resources#emerging or click here.
Drug companies are accused today of endangering public health through widescale marketing malpractices, ranging from covertly attempting to persuade consumers that they are ill to bribing doctors and misrepresenting the results of safety and efficacy tests on their products. In a report that charts the scale of illicit practices by drug companies in the UK and across Europe, Consumers International - the world federation of consumer organisations - says people are not being given facts about the medicines they take because the companies hide the marketing tactics on which they spend billions. "Irresponsible marketing practices form a serious, persistent and widespread problem among the entire pharmaceutical industry," says the report, which analyses the conduct of 20 of the biggest companies. Scandals such as the withdrawal of Vioxx ... show that unethical drug promotion is a consumer concern. Merck withdrew the drug in September 2004, but allegedly knew it could increase the chances of heart attacks and strokes from 2000 and has been accused of manipulating study results to play down the risk. More than 6,000 lawsuits have been filed against the company in the United States by people who claim they suffered heart attacks as a result of the drug. There is no room for complacency when drug companies spend twice as much on marketing as on research...but do not publish information on their drug promotion practices.
The pharmaceutical industry is beginning to reap a windfall from a surprisingly lucrative niche market: drugs for poor people. The windfall, which by some estimates could be $2 billion or more this year, is a result of the transfer of millions of low-income people into the new Medicare Part D drug program that went into effect in January. Under that program...the prices paid by insurers, and eventually the taxpayer, for the medications given to those transferred are likely to be higher than what was paid under the federal-state Medicaid programs. Analysts expect it to generate hundreds of millions of additional dollars this year for the drug companies. Drugs tend to be cheaper under the Medicaid programs because the states are the buyers and by law they receive the lowest available prices for drugs. But in creating the federal Part D program, Congress -- in what critics saw as a sop to the drug industry -- barred the government from having a negotiating role. The windfall for the drug makers was made possible by a provision of the 2003 Medicare law that exempts Part D drugs from "best price" rebates that the drug makers have been required to give to the state Medicaid programs. Those rebates are meant to make sure that state Medicaid agencies pay no more than the best prices drug companies offer to any big commercial insurer. Now, under Part D, all sorts of price deals will be negotiated by dozens of Medicare drug plans. The prices will be reported to Medicare, but under a provision of the law pushed by industry lobbyists, they will otherwise be kept secret.
For the second time in two months, The Journal of the American Medical Association says it was misled by researchers who failed to reveal financial ties to drug companies. The latest incident, disclosed in letters to the editor and a correction in Wednesday's journal, involves a study showing that pregnant women who stop taking antidepressants risk slipping back into depression. Most of the 13 authors have financial ties to drug companies including antidepressant makers, but only two of them revealed their ties when the study was published in February.
Note: To understand how the drug companies manipulate results and even exert tremendous influence over the U.S. Congress, see http://www.WantToKnow.info/healthcoverup
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.